Odonate Therapeutics, Inc.
ODTC
Revenue
0.00
0.000.00%
-Assets
105.77M
▼-12.80M▼-10.80%
3 Months ChangeLiabilities
34.40M
▲454.00k▲1.34%
3 Months ChangeFree Cash Flow
-24.93M
▲2.93M▲10.53%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2022-01-07
Form 8-K
ID: 0001564590-22-000598
2021-11-18
Form 8-K
ID: 0001564590-21-057650
2021-11-10
Form 10-Q
ID: 0001564590-21-056269
2021-08-05
Form 8-K
ID: 0001564590-21-041643
2021-07-27
Form 10-Q
ID: 0001564590-21-038065
2021-06-25
Form 8-K
ID: 0001564590-21-034592
2021-05-14
Form 10-Q
ID: 0001564590-21-027812
2021-03-25
Form 8-K
ID: 0001564590-21-015499
2021-02-23
Form 8-K
ID: 0001564590-21-007307
2020-12-15
Form 8-K
ID: 0001564590-20-057158